Abstract
Neurotransmitters catechol and dopamine analogy levels are related to the systematic nerve activity. This assay was performed by using cyclic voltammetry (CV) and square wave (SW) stripping voltammetry, while optimization was performed by the carbon fiber microelectrode (CFME) with wire-type reference and counter electrodes. In the electrolyte solutions, the analytical parameters of catechol were as follows: 8.5 pH, -0.4 V anodic, 0.3 V cathodic, 15s deposition time, 15 Hz SW frequency, 25 mV SW amplitude and incremental potential of 4 mV, under optimal conditions, working ranges were 0-50 mgL-1 CV, 0.01-50 mgL-1 cathodic, and 1-13 mgL-1 anodic, the relative standard deviation was 0.02 %, n = 15 using 0.5 mgL-1 and the detection limit was 4.0 ugL-1. It can be used for in vivo direct analysis. Here, diagnostic applications were performed in the brain skeleton of living cells in real time. The developed techniques can be useful for nerve control and signal detections.
Keywords: Brain, catechol, dopamine, epinephrine, live fish, micro carbon fiber, skeleton, voltammetry
Current Neurovascular Research
Title: Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System
Volume: 7 Issue: 1
Author(s): Suw Young Ly, Hwa Jin Heo and Min Jung Kim
Affiliation:
Keywords: Brain, catechol, dopamine, epinephrine, live fish, micro carbon fiber, skeleton, voltammetry
Abstract: Neurotransmitters catechol and dopamine analogy levels are related to the systematic nerve activity. This assay was performed by using cyclic voltammetry (CV) and square wave (SW) stripping voltammetry, while optimization was performed by the carbon fiber microelectrode (CFME) with wire-type reference and counter electrodes. In the electrolyte solutions, the analytical parameters of catechol were as follows: 8.5 pH, -0.4 V anodic, 0.3 V cathodic, 15s deposition time, 15 Hz SW frequency, 25 mV SW amplitude and incremental potential of 4 mV, under optimal conditions, working ranges were 0-50 mgL-1 CV, 0.01-50 mgL-1 cathodic, and 1-13 mgL-1 anodic, the relative standard deviation was 0.02 %, n = 15 using 0.5 mgL-1 and the detection limit was 4.0 ugL-1. It can be used for in vivo direct analysis. Here, diagnostic applications were performed in the brain skeleton of living cells in real time. The developed techniques can be useful for nerve control and signal detections.
Export Options
About this article
Cite this article as:
Ly Young Suw, Heo Jin Hwa and Kim Jung Min, Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System, Current Neurovascular Research 2010; 7 (1) . https://dx.doi.org/10.2174/156720210790820154
DOI https://dx.doi.org/10.2174/156720210790820154 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets Cholesterol, Alzheimers Disease, Prion Disorders: A menage a trois?
Current Drug Targets Xanthan Gum Coated Mucoadhesive Liposomes for Efficient Nose to Brain Delivery of Curcumin
Drug Delivery Letters ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases
Central Nervous System Agents in Medicinal Chemistry Cancer Stem Cells and the Biology of Brain Tumors
Current Stem Cell Research & Therapy Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era
Current Molecular Pharmacology GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Current Medicinal Chemistry Therapeutic Development of Interrelated Metabolic and Neurodegenerative Disorders
Current Pharmaceutical Design Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
Current Topics in Medicinal Chemistry Identification of Novel Key Targets and Candidate Drugs in Oral Squamous Cell Carcinoma
Current Bioinformatics Stem cells contributing to postnatal skeletogenesis in the mouse bone marrow
Current Stem Cell Research & Therapy Nucleic Acid Based Therapeutics for Tumor Therapy
Anti-Cancer Agents in Medicinal Chemistry Bv8-Prokineticins and their Receptors: Modulators of Pain
Current Pharmaceutical Biotechnology The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?
Current Drug Targets - CNS & Neurological Disorders Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives
Current Medicinal Chemistry RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point
Anti-Cancer Agents in Medicinal Chemistry Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets Recent Developments on Phenstatins as Potent Antimitotic Agents
Current Medicinal Chemistry ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design